GALECTIN THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
GALECTIN THERAPEUTICS INC. (GALT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 12.54 million shares as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2020-11-09
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12.54M shares.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12.54M shares.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12.54M shares.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12.54M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2020-09-30 | 12.54M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 12.54M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 12.54M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 12.54M shares 10-Q · filed 2020-11-09 |
| 2014-12-31 | 5.47M shares 10-K · filed 2015-03-18 |
| 2014-09-30 | 5.45M shares 10-Q · filed 2014-11-10 |
| 2014-06-30 | 5.45M shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 5.51M shares 10-Q · filed 2014-05-13 |
| 2013-12-31 | 6.04M shares 10-K · filed 2015-03-18 |
| 2013-09-30 | 6.55M shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 7.40M shares 10-Q · filed 2013-08-14 |
| 2013-03-31 | 7.43M shares 10-Q · filed 2013-05-10 |
| 2012-12-31 | 7.42M shares 10-K · filed 2015-03-18 |
| 2012-09-30 | 7.42M shares 10-Q · filed 2012-11-09 |
| 2012-06-30 | 7.42M shares 10-Q · filed 2012-08-10 |
| 2011-12-31 | 6.67M shares 10-K · filed 2014-03-21 |
| 2010-12-31 | 8.59M shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |